Hyperlipidemia clinical trials

Explore recruiting hyperlipidemia clinical trials.

Recruiting hyperlipidemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hyperlipidemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The relationship of cholesterol-lowering drugs with steroid HORMONEs, bile acids, muscle morphology, vitamin D, the immune system and related diseases such as depression and osteoporosis

Austria

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Enlicitide Decanoate Coadministered With Rosuvastatin in Adults With Hyperlipidemia

Spain, Hungary

Therapeutic confirmatory (Phase III) EU CTIS Study details

Phase 1b Study of VERVE-201 in Patients with Refractory Hyperlipidemia

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 2 Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of ARO-APOC3 in Adults with Dyslipidemia

Poland, Hungary, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase III, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Effect of AZD0780 on Low-Density Lipoprotein Cholesterol in Patients With Elevated Low-Density Lipoprotein Cholesterol and Clinical Atherosclerotic Cardiovascular Disease or at Risk for a First Atherosclerotic Cardiovascular Disease Event

Bulgaria, Poland, Slovakia, Hungary, Czechia, Spain +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Evaluation of the benefits of Administering immunosuppressive drugs as Single daily doses over the first Year after liver transplantation

France

Therapeutic use (Phase IV) EU CTIS Study details

Hyperlipidemia trials by city

Hyperlipidemia in Toronto Hyperlipidemia in Vancouver Hyperlipidemia in Montreal Hyperlipidemia in Calgary Hyperlipidemia in Edmonton Hyperlipidemia in Ottawa Hyperlipidemia in Winnipeg Hyperlipidemia in Quebec City Hyperlipidemia in Hamilton Hyperlipidemia in Kitchener Hyperlipidemia in London Hyperlipidemia in Halifax Hyperlipidemia in New York Hyperlipidemia in Los Angeles Hyperlipidemia in Chicago Hyperlipidemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease